These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

289 related items for PubMed ID: 4918918

  • 1. [Time relationship between the appearance of persisting extrapyramidal hyperkineses and psychotic recurrences following sudden interruption of prolonged neuroleptic therapy of chronic schizophrenic patients].
    Degkwitz R, Bauer MP, Gruber M, Hampel G, Luxenburger O, Richartz M, Wenzel W.
    Arzneimittelforschung; 1970 Jul; 20(7):890-3. PubMed ID: 4918918
    [No Abstract] [Full Text] [Related]

  • 2. [Study of the delayed-action form of a synthetic antiparkinsonian drug: Akineton].
    Kammerer T, Schweitzer-Bucher E, Jamet P, Royer M.
    Ann Med Psychol (Paris); 1972 May; 1(5):688-96. PubMed ID: 5081112
    [No Abstract] [Full Text] [Related]

  • 3. [Transitory exacerbations arising during the course of neuroleptic therapy].
    Gurovich IIa.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(6):919-25. PubMed ID: 5471621
    [No Abstract] [Full Text] [Related]

  • 4. [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Lange J.
    Arzneimittelforschung; 1970 Jul; 20(7):888-90. PubMed ID: 5536050
    [No Abstract] [Full Text] [Related]

  • 5. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Jul; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study of TPS-23, chlorpromazine and placebo in chronic schizophrenic patients.
    Tetreault L, Bordeleau JM, Gauthier R, Vulpe M, Lapointe L.
    Dis Nerv Syst; 1969 Feb; 30(2):Suppl:74-84. PubMed ID: 4886994
    [No Abstract] [Full Text] [Related]

  • 7. [Effects of neuroleptic withdrawal on the drug-induced extrapyramidal syndrome of chronic schizophrenia].
    Elie R, Gagnon MA, Gauthier R, Jéquier JC.
    Union Med Can; 1975 Jun; 104(6):909-14. PubMed ID: 772906
    [No Abstract] [Full Text] [Related]

  • 8. [Extrapyramidal hyperkineses following prior cerebral damage and long-term therapy using neuroleptics: ballistic syndrome, "hysteroid" attacks and hyopharyngeal syndrome with special reference to the clinical picture: misdiagnosis of the disorders as psychogenic and schizophrenic symptoms].
    Meyendorf R.
    Schweiz Arch Neurol Neurochir Psychiatr; 1969 Jun; 105(1):165-76. PubMed ID: 4903648
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
    Luckey WT, Schiele BC.
    Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and ergotherapeutic evaluation of fluspirilene (R 6218), a long-acting injectable neuroleptic, in chronic psychotic patients.
    Tanghe A, Vereecken JL.
    Psychiatr Neurol Neurochir; 1971 Mar; 74(5):379-89. PubMed ID: 5138128
    [No Abstract] [Full Text] [Related]

  • 14. [Report on the clinical testing of the delayed-action form of the neuroleptic agent moperone hydrochloride in 20 chronic psychotic patients].
    Lydecken K.
    Schweiz Arch Neurol Neurochir Psychiatr; 1977 Mar; 120(1):75-82. PubMed ID: 323966
    [Abstract] [Full Text] [Related]

  • 15. [On the position of the butyrophenone derivative Haloperidol in psychiatric treatment].
    Greger J, Glitschka A, Müller K.
    Psychiatr Neurol Med Psychol (Leipz); 1968 Jun; 20(7):241-52. PubMed ID: 5731879
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Logemann G.
    Arzneimittelforschung; 1970 Jul; 20(7):894-6. PubMed ID: 5536051
    [No Abstract] [Full Text] [Related]

  • 17. A preliminary study of Thiothixene in chronic schizophrenics.
    Simpson GM, Iqbal J.
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):697-700. PubMed ID: 4953690
    [No Abstract] [Full Text] [Related]

  • 18. [Drug withdrawal symptoms following cessation of prolonged neuroleptic therapy].
    Krystof J, Zyg J, Mitkiewicz S, Kaczyński J.
    Psychiatr Pol; 1971 Nov; 5(4):417-23. PubMed ID: 5112317
    [No Abstract] [Full Text] [Related]

  • 19. Antipsychotic properties of loxapine succinate.
    Gershon S, Hekimian LJ, Burdock EI, Kim SS.
    Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.